🔎 Trials Near Me

Hem › KOL › Texas › Houston

Kliniska studier för KOL i Houston, TX

15 studier för KOL söker deltagare vid platser i och runt Houston (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

RekryterarFas 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Ålder 40 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

RekryterarFas 3
  • Se Houston- Site Number : 8400120, Houston
  • Aavon Clinical Trials, Llc- Site Number : 8400166, Houston
Ålder 40 till 80 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07190222

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

RekryterarFas 2
  • Baylor College of Medicine Medical Center, Houston
Ålder 40 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RekryterarFas 3
  • Trio Clinical Trials- Site Number : 8400106, Houston
  • HDH Research- Site Number : 8400104, Houston
  • Baylor College of Medicine- Site Number : 8400076, Houston
  • och 2 fler
Ålder 40 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RekryterarFas 2
  • Research Site, Houston
Ålder 40 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

RekryterarFas 2
  • Baylor College of Medicine, Houston
Ålder 40 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

RekryterarFas 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RekryterarFas 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Humble · 17 mi bort
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RekryterarFas 2/3
  • Greater Heights & Memorial Pulmonary and Sleep, Houston
  • Houston Pulmonary Sleep and Allergy Associates, Houston
Ålder 35 till 80 · Alla kön · Uppdaterad 31 aug. 2026 · NCT07363694

STRIVE Post-Market Registry Study

RekryterarObservationsstudie
  • University of Texas Health Science Center at Houston, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 3 aug. 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RekryterarFas 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
Ålder 40 till 75 · Alla kön · Uppdaterad 28 juli 2026 · NCT07177339

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Rekryterar
  • Houston Methodist/Primary Critical Care, Houston
Ålder 40 till 84 · Alla kön · Uppdaterad 24 apr. 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

RekryterarFas 3
  • GSK Investigational Site, Houston
Ålder 40 till 80 · Alla kön · Uppdaterad 9 apr. 2026 · NCT06961214

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

RekryterarObservationsstudie
  • Horizon Clinical Research Group, Houston
Ålder 50 och äldre · Alla kön · Uppdaterad 5 aug. 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Rekryterar
  • Respire Research Institute, Houston
Ålder 30 och äldre · Alla kön · Uppdaterad 6 feb. 2025 · NCT05204888

KOL-studier i andra städer

Andra studier i Houston

Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.